{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:39:02Z","timestamp":1787009942348,"version":"build-2736575974"},"reference-count":105,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:p>The primary site of infection in COVID-19 exhibit is the respiratory system, but multiple organ systems could be affected. The virus could directly invade cardiomyocytes. Alternatively, cytokine storm could lead to myocardial injury. More importantly, the management of existing cardiovascular diseases must be re-examined in COVID-19 due to, for example, interaction between antiviral agents and with a wide variety of pharmacological agents. The Branch of Cardiovascular Physicians of Chinese Medical Doctor Association organized a panel of experts in cardiovascular and related fields to discuss this important issue, and formulated the \u201c2023 Chinese Expert Consensus on the Impact of COVID-19 on the Management of Cardiovascular Diseases.\u201d The Consensus was drafted on the basis of systematic review of existing evidence and diagnosis and treatment experience, and covers three major aspects: myocardial injury caused by COVID-10 and COVID-19 vaccine, the impact of COVID-19 on patients with cardiovascular disease, and the impact of COVID-19 on the cardiovascular system of healthy people, and rehabilitation guidance recommendations. The Consensus involves 11 core clinical issues, including incidence, pathogenesis, clinical manifestations, treatment strategies, prognosis, and rehabilitation. It is our hope that this Consensus will provide a practical guidance to cardiologists in the management of cardiovascular diseases in the new era of COVID-19 pandemic.<\/jats:p>","DOI":"10.1097\/cp9.0000000000000043","type":"journal-article","created":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T04:07:14Z","timestamp":1683605234000},"page":"82-102","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["2023 Chinese expert consensus on the impact of COVID-19 on the management of cardiovascular diseases"],"prefix":"10.1097","volume":"8","author":[{"name":"Branch of Cardiovascular Physicians of Chinese Medical Doctor Association","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,7,20]]},"reference":[{"key":"R1-20250822","article-title":"Primary assessment of the diversity of omicron sublineages and the epidemiologic features of autumn\/winter 2022 COVID-19 wave in Chinese Mainland","author":"Lu","year":"2022","journal-title":"Front Med"},{"key":"R4-20250822","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor.","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"R5-20250822","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1161\/CIRCULATIONAHA.120.046941","article-title":"COVID-19 and cardiovascular disease.","volume":"141","author":"Clerkin","year":"2020","journal-title":"Circulation"},{"key":"R6-20250822","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention.","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"R7-20250822","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1161\/CIRCULATIONAHA.120.049465","article-title":"Unexpected features of cardiac pathology in COVID-19 infection.","volume":"142","author":"Fox","year":"2020","journal-title":"Circulation"},{"key":"R8-20250822","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.7326\/L20-0882","article-title":"Cardiac endotheliitis and multisystem inflammatory syndrome after COVID-19.","volume":"173","author":"Fox","year":"2020","journal-title":"Ann Intern Med"},{"key":"R9-20250822","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1001\/jama.2020.8907","article-title":"Postmortem examination of patients with COVID-19.","volume":"323","author":"Schaller","year":"2020","journal-title":"JAMA"},{"key":"R10-20250822","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jacbts.2021.01.002","article-title":"SARS-CoV-2 infects human engineered heart tissues and models COVID-19 myocarditis.","volume":"6","author":"Bailey","year":"2021","journal-title":"JACC Basic Transl Sci"},{"key":"R11-20250822","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.stemcr.2020.11.003","article-title":"Using cardiovascular cells from human pluripotent stem cells for COVID-19 research: why the heart fails.","volume":"16","author":"Yiangou","year":"2021","journal-title":"Stem Cell Rep"},{"key":"R12-20250822","doi-asserted-by":"crossref","first-page":"469580221093442","DOI":"10.1177\/00469580221093442","article-title":"The effects of the SARS-CoV-2 virus on the cardiovascular system and coagulation state leading to cardiovascular diseases: a narrative review.","volume":"59","author":"Bhat","year":"2022","journal-title":"Inquiry"},{"key":"R13-20250822","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1093\/cvr\/cvaa267","article-title":"SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes.","volume":"116","author":"Bojkova","year":"2020","journal-title":"Cardiovasc Res"},{"key":"R14-20250822","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1001\/jamacardio.2020.3551","article-title":"Association of cardiac infection with SARS-CoV-2 in confirmed COVID-19 autopsy cases.","volume":"5","author":"Lindner","year":"2020","journal-title":"JAMA Cardiol"},{"key":"R15-20250822","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/s41422-021-00523-8","article-title":"A cohort autopsy study defines COVID-19 systemic pathogenesis.","volume":"31","author":"Yao","year":"2021","journal-title":"Cell Res"},{"key":"R16-20250822","article-title":"The SARS-CoV-2 Spike protein induces long-term transcriptional perturbations of mitochondrial metabolic genes, causes cardiac fibrosis, and reduces myocardial contractile in obese mice.","author":"Cao","year":"2023","journal-title":"bioRxiv"},{"key":"R17-20250822","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41392-022-01256-9","article-title":"Strong attenuation of SARS-CoV-2 Omicron BA.1 and increased replication of the BA.5 subvariant in human cardiomyocytes.","volume":"7","author":"Nchioua","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"R18-20250822","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa2028700","article-title":"Tocilizumab in hospitalized patients with severe covid-19 pneumonia.","volume":"384","author":"Rosas","year":"2021","journal-title":"N Engl J Med"},{"key":"R19-20250822","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1097\/CCM.0000000000002053","article-title":"Cytokine release syndrome after chimeric antigen receptor T cell therapy for acute lymphoblastic leukemia.","volume":"45","author":"Fitzgerald","year":"2017","journal-title":"Crit Care Med"},{"key":"R20-20250822","doi-asserted-by":"crossref","first-page":"e20201129","DOI":"10.1084\/jem.20201129","article-title":"SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology.","volume":"217","author":"Veras","year":"2020","journal-title":"J Exp Med"},{"key":"R21-20250822","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1182\/blood.2020007214","article-title":"Platelet gene expression and function in patients with COVID-19.","volume":"136","author":"Manne","year":"2020","journal-title":"Blood"},{"key":"R22-20250822","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2.","volume":"367","author":"Yan","year":"2020","journal-title":"Science"},{"key":"R23-20250822","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","article-title":"Renin-angiotensin-aldosterone system inhibitors in patients with covid-19.","volume":"382","author":"Vaduganathan","year":"2020","journal-title":"N Engl J Med"},{"key":"R24-20250822","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.jacc.2022.02.003","article-title":"2022 ACC Expert consensus decision pathway on cardiovascular sequelae of COVID-19 in adults: myocarditis and other myocardial involvement, post-acute sequelae of SARS-CoV-2 infection, and return to play: a report of the American College of Cardiology Solution Set Oversight Committee.","volume":"79","author":"Gluckman","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"R25-20250822","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/ejhf.2247","article-title":"Prevalence and outcome of patients with acute myocarditis and positive viral search on nasopharyngeal swab.","volume":"23","author":"Ammirati","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"R26-20250822","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41569-020-00435-x","article-title":"Myocarditis and inflammatory cardiomyopathy: current evidence and future directions.","volume":"18","author":"Tsch\u00f6pe","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"R27-20250822","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1161\/CIRCULATIONAHA.121.056817","article-title":"Prevalence, characteristics, and outcomes of COVID-19-associated acute myocarditis.","volume":"145","author":"Ammirati","year":"2022","journal-title":"Circulation"},{"key":"R28-20250822","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ccep.2021.11.001","article-title":"Prevalence and clinical implications of COVID-19 myocarditis.","volume":"14","author":"Chimenti","year":"2022","journal-title":"Card Electrophysiol Clin"},{"key":"R29-20250822","doi-asserted-by":"crossref","first-page":"6999","DOI":"10.3390\/jcm11236999","article-title":"Myocarditis related to COVID-19 and SARS-CoV-2 vaccination.","volume":"11","author":"Molina-Ramos","year":"2022","journal-title":"J Clin Med"},{"key":"R30-20250822","doi-asserted-by":"crossref","first-page":"362","DOI":"10.7326\/M21-3700","article-title":"Carditis after COVID-19 vaccination with a messenger RNA vaccine and an inactivated virus vaccine: a case-control study.","volume":"175","author":"Lai","year":"2022","journal-title":"Ann Intern Med"},{"key":"R31-20250822","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Fourth universal definition of myocardial infarction (2018).","volume":"72","author":"Thygesen","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R32-20250822","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10741-021-10087-9","article-title":"COVID-19 and myocarditis: a systematic review and overview of current challenges.","volume":"27","author":"Castiello","year":"2022","journal-title":"Heart Fail Rev"},{"key":"R33-20250822","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1016\/j.jcmg.2020.06.003","article-title":"Cardiac magnetic resonance characterization of myocarditis-like acute cardiac syndrome in COVID-19.","volume":"13","author":"Esposito","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"R34-20250822","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa2118542","article-title":"Oral nirmatrelvir for high-risk, nonhospitalized adults with COVID-19.","volume":"386","author":"Hammond","year":"2022","journal-title":"N Engl J Med"},{"key":"R35-20250822","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJMoa2116044","article-title":"Molnupiravir for oral treatment of COVID-19 in nonhospitalized patients.","volume":"386","author":"Jayk Bernal","year":"2022","journal-title":"N Engl J Med"},{"key":"R36-20250822","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41392-021-00835-6","article-title":"Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patients.","volume":"6","author":"Zhang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"R37-20250822","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/jama.2022.23257","article-title":"Long-term (180-day) outcomes in critically ill patients with COVID-19 in the REMAP-CAP randomized clinical trial.","volume":"329","author":"Higgins","year":"2023","journal-title":"JAMA"},{"key":"R38-20250822","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with COVID-19.","volume":"384","author":"Horby","year":"2021","journal-title":"N Engl J Med"},{"key":"R39-20250822","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S2213-2600(21)00440-9","article-title":"Intravenous immunoglobulins in patients with COVID-19-associated moderate-to-severe acute respiratory distress syndrome (ICAR): multicentre, double-blind, placebo-controlled, phase 3 trial.","volume":"10","author":"Mazeraud","year":"2022","journal-title":"Lancet Respir Med"},{"key":"R40-20250822","doi-asserted-by":"crossref","first-page":"e2397","DOI":"10.1002\/rmv.2397","article-title":"Intravenous immunoglobulin (IVIg) therapy in hospitalised adult COVID-19 patients: a systematic review and meta-analysis.","volume":"32","author":"Marcec","year":"2022","journal-title":"Rev Med Virol"},{"key":"R41-20250822","first-page":"742","article-title":"Chinese expert consensus on diagnosis and treatment of adult fulminant myocarditis.","volume":"45","year":"2017","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"R42-20250822","first-page":"277","article-title":"Mechanical circulatory support combined with immunomodulation treatment for patients with fulminant myocarditis: a single-center real-world study.","volume":"50","author":"Jie","year":"2022","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"R43-20250822","first-page":"145","article-title":"Chinese Expert Consensus on clinical application and management of percutaneous mechanical circulatory assistance.","volume":"04","year":"2020","journal-title":"Chin J Heart Fail Cardiomyopathy"},{"key":"R44-20250822","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/SHK.0000000000001611","article-title":"Short-term efficacy and safety of different mechanical hemodynamic support devices for cardiogenic shock or high-risk pci: a network meta-analysis of thirty-seven trials.","volume":"55","author":"Duan","year":"2021","journal-title":"Shock"},{"key":"R45-20250822","doi-asserted-by":"crossref","first-page":"e924009","DOI":"10.12659\/MSM.924009","article-title":"Outcomes of VA-ECMO with and without left centricular (LV) decompression using intra-aortic balloon pumping (IABP) versus other LV decompression techniques: a systematic review and meta-analysis.","volume":"26","author":"Pan","year":"2020","journal-title":"Med Sci Monit"},{"key":"R46-20250822","first-page":"376","article-title":"Percutaneous impella RP use for refractory right heart failure in adolescents and young adults-A multicenter U.S. experience.","volume":"96","author":"Qureshi","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"key":"R47-20250822","doi-asserted-by":"crossref","first-page":"e007405","DOI":"10.1161\/CIRCHEARTFAILURE.120.007405","article-title":"Management of acute myocarditis and chronic inflammatory cardiomyopathy: an expert consensus document.","volume":"13","author":"Ammirati","year":"2020","journal-title":"Circ Heart Fail"},{"key":"R48-20250822","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ajem.2021.10.001","article-title":"COVID-19 associated myocarditis: a systematic review.","volume":"51","author":"Haussner","year":"2022","journal-title":"Am J Emerg Med"},{"key":"R49-20250822","doi-asserted-by":"crossref","first-page":"e1037","DOI":"10.1161\/CIR.0000000000001064","article-title":"SARS-CoV-2 infection and associated cardiovascular manifestations and complications in children and young adults: a scientific statement from the American Heart Association.","volume":"145","author":"Jone","year":"2022","journal-title":"Circulation"},{"key":"R50-20250822","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1016\/j.jinf.2020.04.021","article-title":"Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis.","volume":"81","author":"Zheng","year":"2020","journal-title":"J Infect"},{"key":"R51-20250822","doi-asserted-by":"crossref","first-page":"100507","DOI":"10.1016\/j.eclinm.2020.100507","article-title":"COVID-19: risk factors for critical illness.","volume":"25","author":"Gao","year":"2020","journal-title":"EClinicalMedicine"},{"key":"R52-20250822","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1016\/j.jacc.2015.09.046","article-title":"Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 14: sickle cell trait: a scientific statement from the American Heart Association and American College of Cardiology.","volume":"66","author":"Maron","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"R53-20250822","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/jamacardio.2020.5890","article-title":"Coronavirus disease 2019 and the athletic heart: emerging perspectives on pathology, risks, and return to play.","volume":"6","author":"Kim","year":"2021","journal-title":"JAMA Cardiol"},{"key":"R54-20250822","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1001\/jama.2022.17876","article-title":"Association of primary and booster vaccination and prior infection with SARS-CoV-2 infection and severe COVID-19 outcomes.","volume":"328","author":"Lin","year":"2022","journal-title":"JAMA"},{"key":"R55-20250822","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0140-6736(22)01656-7","article-title":"Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales.","volume":"400","author":"Agrawal","year":"2022","journal-title":"Lancet"},{"key":"R56-20250822","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1056\/NEJMra2114478","article-title":"Myocarditis.","volume":"387","author":"Basso","year":"2022","journal-title":"N Engl J Med"},{"key":"R57-20250822","doi-asserted-by":"crossref","first-page":"977","DOI":"10.15585\/mmwr.mm7027e2","article-title":"Use of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: update from the advisory committee on immunization practices - United States, June 2021.","volume":"70","author":"Gargano","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R58-20250822","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1056\/NEJMoa2110737","article-title":"Myocarditis after COVID-19 vaccination in a large health care organization.","volume":"385","author":"Witberg","year":"2021","journal-title":"N Engl J Med"},{"key":"R59-20250822","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa2109730","article-title":"Myocarditis after BNT162b2 mRNA vaccine against COVID-19 in Israel.","volume":"385","author":"Mevorach","year":"2021","journal-title":"N Engl J Med"},{"key":"R60-20250822","doi-asserted-by":"crossref","first-page":"e068665","DOI":"10.1136\/bmj-2021-068665","article-title":"SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study.","volume":"375","author":"Husby","year":"2021","journal-title":"BMJ"},{"key":"R61-20250822","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41591-021-01630-0","article-title":"Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection.","volume":"28","author":"Patone","year":"2022","journal-title":"Nat Med"},{"key":"R62-20250822","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1161\/CIRCULATIONAHA.121.056135","article-title":"Myocarditis with COVID-19 mRNA vaccines.","volume":"144","author":"Bozkurt","year":"2021","journal-title":"Circulation"},{"key":"R63-20250822","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/eurheartj\/ehab697","article-title":"ESC Guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up.","volume":"43","year":"2022","journal-title":"Eur Heart J"},{"key":"R64-20250822","first-page":"330","article-title":"Cardiovascular risk factors, cardiovascular disease, and COVID-19: an umbrella review of systematic reviews.","volume":"7","author":"Harrison","year":"2021","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"R65-20250822","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.4244\/EIJ-D-20-00935","article-title":"In-hospital outcomes of COVID-19 ST-elevation myocardial infarction patients.","volume":"16","author":"Rodriguez-Leor","year":"2021","journal-title":"EuroIntervention"},{"key":"R66-20250822","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes.","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur Heart J"},{"key":"R67-20250822","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1002\/ejhf.1990","article-title":"Heart failure in COVID-19 patients: prevalence, incidence and prognostic implications.","volume":"22","author":"Rey","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"R68-20250822","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"R69-20250822","doi-asserted-by":"crossref","first-page":"18028","DOI":"10.1038\/nrdp.2018.28","article-title":"Pulmonary embolism.","volume":"4","author":"Huisman","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"R70-20250822","doi-asserted-by":"crossref","first-page":"e009121","DOI":"10.1161\/CIRCEP.120.009121","article-title":"Arrhythmic complications of patients hospitalized with COVID-19: incidence, risk factors, and outcomes.","volume":"13","author":"Peltzer","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R71-20250822","doi-asserted-by":"crossref","first-page":"e13387","DOI":"10.1111\/eci.13387","article-title":"Clinical characteristics and prognosis of hospitalized COVID-19 patients with incident sustained tachyarrhythmias: a multicenter observational study.","volume":"50","author":"Russo","year":"2020","journal-title":"Eur J Clin Invest"},{"key":"R72-20250822","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jacep.2020.05.015","article-title":"Atrial arrhythmias in COVID-19 patients.","volume":"6","author":"Colon","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"key":"R73-20250822","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY.","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"R74-20250822","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1001\/jama.2020.25864","article-title":"Effect of discontinuing vs continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on days alive and out of the hospital in patients admitted with COVID-19: a randomized clinical trial.","volume":"325","author":"Lopes","year":"2021","journal-title":"JAMA"},{"key":"R75-20250822","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S2213-2600(20)30558-0","article-title":"Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial.","volume":"9","author":"Cohen","year":"2021","journal-title":"Lancet Respir Med"},{"key":"R76-20250822","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jpeds.2020.06.076","article-title":"SARS-CoV-2 infection in patients with down syndrome, congenital heart disease, and pulmonary hypertension: is down syndrome a risk factor.","volume":"225","author":"Krishnan","year":"2020","journal-title":"J Pediatr"},{"key":"R77-20250822","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1001\/jamacardio.2020.2159","article-title":"Characteristics and outcomes of recipients of heart transplant with coronavirus disease 2019.","volume":"5","author":"Latif","year":"2020","journal-title":"JAMA Cardiol"},{"key":"R78-20250822","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.healun.2020.03.008","article-title":"Epidemiologic and clinical characteristics of heart transplant recipients during the 2019 coronavirus outbreak in Wuhan, China: A descriptive survey report.","volume":"39","author":"Ren","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"R79-20250822","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.jaccas.2020.05.068","article-title":"Stress-induced cardiomyopathy precipitated by COVID-19 and influenza a coinfection.","volume":"2","author":"Sang","year":"2020","journal-title":"JACC Case Rep"},{"key":"R80-20250822","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s00228-022-03356-5","article-title":"Does aspirin have an effect on risk of death in patients with COVID-19? A meta-analysis.","volume":"78","author":"Ma","year":"2022","journal-title":"Eur J Clin Pharmacol"},{"key":"R81-20250822","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1093\/eurheartj\/ehaa373","article-title":"Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors.","volume":"41","author":"Sama","year":"2020","journal-title":"Eur Heart J"},{"key":"R82-20250822","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/ajh\/hpac001","article-title":"Effects of Renin-Angiotensin system inhibitors on mortality and disease severity of COVID-19 patients: a meta-analysis of randomized controlled trials.","volume":"35","author":"Yin","year":"2022","journal-title":"Am J Hypertens"},{"key":"R83-20250822","doi-asserted-by":"crossref","first-page":"e004675","DOI":"10.1161\/JAHA.116.004675","article-title":"Initiation, continuation, or withdrawal of angiotensin-converting enzyme inhibitors\/angiotensin receptor blockers and outcomes in patients hospitalized with heart failure with reduced ejection fraction.","volume":"6","author":"Gilstrap","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"R84-20250822","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/eurheartj\/ehab696","article-title":"European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis.","volume":"43","year":"2022","journal-title":"Eur Heart J"},{"key":"R85-20250822","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1111\/jth.15808","article-title":"ISTH guidelines for antithrombotic treatment in COVID-19.","volume":"20","author":"Schulman","year":"2022","journal-title":"J Thromb Haemost"},{"key":"R86-20250822","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/j.jacc.2022.08.800","article-title":"Cardiovascular drug interactions with Nirmatrelvir\/Ritonavir in patients with COVID-19: JACC review topic of the week.","volume":"80","author":"Abraham","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"R87-20250822","first-page":"503","article-title":"Effects of the antiretroviral drug 2\u2019-deoxy-2\u2019-\u03b2-fluoro-4\u2019-azidocytidine (FNC) on P-gp, MRP2 and BCRP expressions and functions.","volume":"73","author":"Liu","year":"2018","journal-title":"Pharmazie"},{"key":"R88-20250822","doi-asserted-by":"crossref","first-page":"e2130645","DOI":"10.1001\/jamanetworkopen.2021.30645","article-title":"Assessment of cognitive function in patients after COVID-19 infection.","volume":"4","author":"Becker","year":"2021","journal-title":"JAMA Netw Open"},{"key":"R89-20250822","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/d41586-022-02074-3","article-title":"Heart disease after COVID: what the data say.","volume":"608","author":"Sidik","year":"2022","journal-title":"Nature"},{"key":"R90-20250822","doi-asserted-by":"crossref","first-page":"e2101222","DOI":"10.1002\/advs.202101222","article-title":"Combined metabolic activators accelerates recovery in mild-to-moderate COVID-19.","volume":"8","author":"Altay","year":"2021","journal-title":"Adv Sci (Weinh)"},{"key":"R91-20250822","first-page":"2925","article-title":"Effects of Qi Dong Yi Xin combined with adenosine cyclophosphate meglumine on myocardial enzyme spectrum, cellular immune function and plasma atrial natriuretic peptide level in patients with myocarditis.","volume":"28","author":"Sun","year":"2019","journal-title":"Mod J Integra Tradit Chin West Med"},{"key":"R92-20250822","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1055\/s-0040-1710019","article-title":"Prevention and treatment of venous thromboembolism associated with coronavirus disease 2019 infection: a consensus statement before guidelines.","volume":"120","author":"Zhai","year":"2020","journal-title":"Thromb Haemost"},{"key":"R93-20250822","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1001\/jama.2021.17272","article-title":"Effect of antithrombotic therapy on clinical outcomes in outpatients with clinically stable symptomatic COVID-19: the ACTIV-4B randomized clinical trial.","volume":"326","author":"Connors","year":"2021","journal-title":"JAMA"},{"key":"R94-20250822","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41577-022-00762-9","article-title":"Understanding COVID-19-associated coagulopathy.","volume":"22","author":"Conway","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"R95-20250822","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/SHK.0000000000001660","article-title":"COVID-19 Associated hypercoagulability: manifestations, mechanisms, and management.","volume":"55","author":"Mazzeffi","year":"2021","journal-title":"Shock"},{"key":"R96-20250822","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1161\/CIRCULATIONAHA.120.047430","article-title":"Pulmonary embolism in patients with COVID-19: awareness of an increased prevalence.","volume":"142","author":"Poissy","year":"2020","journal-title":"Circulation"},{"key":"R97-20250822","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1056\/NEJMc2009787","article-title":"Large-vessel stroke as a presenting feature of covid-19 in the young.","volume":"382","author":"Oxley","year":"2020","journal-title":"N Engl J Med"},{"key":"R98-20250822","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/j.jvs.2020.04.483","article-title":"Acute limb ischemia in patients with COVID-19 pneumonia.","volume":"72","author":"Bellosta","year":"2020","journal-title":"J Vasc Surg"},{"key":"R99-20250822","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jacc.2020.05.001","article-title":"Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19.","volume":"76","author":"Paranjpe","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"R100-20250822","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1001\/jamacardio.2021.0565","article-title":"Prevalence of inflammatory heart disease among professional athletes with prior COVID-19 infection who received systematic return-to-play cardiac screening.","volume":"6","author":"Martinez","year":"2021","journal-title":"JAMA Cardiol"},{"key":"R101-20250822","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1161\/CIRCULATIONAHA.121.054824","article-title":"SARS-CoV-2 cardiac involvement in young competitive athletes.","volume":"144","author":"Moulson","year":"2021","journal-title":"Circulation"},{"key":"R102-20250822","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1001\/jamacardio.2021.2065","article-title":"Prevalence of clinical and subclinical myocarditis in competitive athletes with recent SARS-CoV-2 infection: results from the big ten COVID-19 cardiac registry.","volume":"6","author":"Daniels","year":"2021","journal-title":"JAMA Cardiol"},{"key":"R103-20250822","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1001\/jamacardio.2020.2136","article-title":"A game plan for the resumption of sport and exercise after coronavirus disease 2019 (COVID-19) infection.","volume":"5","author":"Phelan","year":"2020","journal-title":"JAMA Cardiol"},{"key":"R104-20250822","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1136\/bjsports-2020-102710","article-title":"Cardiorespiratory considerations for return-to-play in elite athletes after COVID-19 infection: a practical guide for sport and exercise medicine physicians.","volume":"54","author":"Wilson","year":"2020","journal-title":"Br J Sports Med"},{"key":"R105-20250822","doi-asserted-by":"crossref","first-page":"m4721","DOI":"10.1136\/bmj.m4721","article-title":"Returning to physical activity after covid-19.","volume":"372","author":"Salman","year":"2021","journal-title":"BMJ"},{"key":"R106-20250822","first-page":"e273","article-title":"Eligibility and sisqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 3: hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: a scientific statement from the American Heart Association and American College of Cardiology.","volume":"132","author":"Maron","year":"2015","journal-title":"Circulation"},{"key":"R107-20250822","doi-asserted-by":"crossref","first-page":"101762","DOI":"10.1016\/j.eclinm.2022.101762","article-title":"The prevalence and long-term health effects of long COVID among hospitalised and non-hospitalised populations: a systematic review and meta-analysis.","volume":"55","author":"O\u2019Mahoney","year":"2023","journal-title":"EClinicalMedicine"}],"container-title":["Cardiology Plus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CP9.0000000000000043","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T03:07:42Z","timestamp":1755832062000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CP9.0000000000000043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":105,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/cp9.0000000000000043","relation":{},"ISSN":["2470-7511"],"issn-type":[{"value":"2470-7511","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]}}}